Research at University Health Network
 
Technology Transfer
Menu Level 3  
   
  Find a ...
 

 Researcher
 Facility
 Career at UHN


  Research News
 

 Read UHN's Research  Newsletter


  Quick Links
   UHN Research Intranet
 UHN Corporate www
 UHN Corporate Intranet


  Remote Tools & Access
   Staff Remote Access
 Research Webmail
 SecureDoc Viewers
 CAPCR Remote Login  Good Clinical Research  Practice: Principles
 e-learning program

Subscribe to UHN Research's RSS feed:

 
   

Princess Margaret Cancer Institute Techna Institute Toronto General Research Institute Toronto Rehabilitation Institute Toronto Western Research Institute

Princess Margaret Cancer Centre

Techna Institute

Toronto General Research Institute

Toronto Rehab Institute

Toronto Western Research Institute


  • Research foci: cancer— genomics, informatics, molecular biology, clinical trials, signalling pathways, structural biology and biophysics.
  • 376 scientists and clinician-scientists
  • $150M external funding
  • more


  • Headquartered at the Banting Building
  • Research foci: guided therapeutics, informatics and communication technologies, nanotechnology and radiochemistry, photonics, design and engineering for health
  • 50 scientists and clinician-scientists
  • more

  • Located at the Toronto General Hospital
  • Research foci: cardiology, transplantation, immunology and infectious disease
  • 256 scientists and clinician-scientists
  • $74M external funding
  • more

  • Located at Toronto Rehab
  • Research foci: rehabilitation sciences, cardiopulmonary fitness and mobility
  • 118 scientists and clinician-scientists
  • $9M external funding
  • more

  • Located at the Toronto Western Hospital
  • Research foci: Neural and visual sciences, musculoskeletal disease and community and population health
  • 161 scientists and clinician-scientists
  • $37M external funding
  • more
 


Cancer: New Drug Mechanism Unveiled
Aug 28, 2015

A team of researchers led by Dr. Daniel De Carvalho (Scientist, Princess Margaret Cancer Centre) has discovered a new therapeutic strategy that could lead to more effective treatments for colorectal cancer.

The team showed that treating colorectal cancer cells with the chemotherapy drug decitabine activates pathways that make the cells grow and proliferate more slowly and behave like they are infected with viruses; as a consequence of this, the cells are targeted and cleared by the immune system. They also demonstrated that colorectal cancer stem cells—a subset of cells within a tumour that can resist treatment and promote relapse—are also susceptible to decitabine.

This exciting discovery was published online on August 27th by the journal Cell, one of the most prestigious and well-respected scientific journals currently in print. Click here to read the abstract (Photo: UHN).


Full Story

Government Funds Stem Cell Research
Aug 26, 2015

University of Toronto stem cell researchers were recently awarded a grant worth an unprecedented $114 million that is aimed at helping them translate their promising research discoveries into more effective therapies for patients in Canada and worldwide. It is one of five projects that will receive funding under the inaugural Canada First Research Excellence Fund program competition, which was launched by the federal government in 2014.


Full Story

UHN Oncologist a Leader in Supportive Care
Aug 24, 2015

Dr. David Warr is now entering his second year as President of the Multinational Association of Supportive Care in Cancer (MASCC). The appointment has allowed Dr. Warr to advance research and education in all aspects of supportive care for people with cancer, regardless of the stage of their disease--a key focus of MASCC. At UHN's PM Cancer Centre, Dr. Warr is Head of the Medical Oncology Breast Group, where he is an expert in pain, symptom and nausea management for those with cancer.


Full Story

 

   
 
 
 
Home Researchers Facilities Support Services Programs Commercialization Ethics News About UHN Institutes OCI Techna TGRI TRI TWRI hyperlink to UHNResearchnews Facebook page hyperlink to UHNResearch Twitter feed